Indonesian Prenatal Institute’s Post

#OriginalResearch Title: Determinants of Postpartum Hemorrhage Incidence in the Maospati Magetan Health Center Working Area in 2023, Indonesia Author: Dannisa Putri Dharma Health Dynamics, Volume 1, Issue 6 (June 2024) DOI Link: https://lnkd.in/gafqnJBK Keywords: #UnderFiveChildren #EstimationModel #Prevalence #Stunting Contact Website: https://lnkd.in/dhvkbGET Email: healthdynamics.journal@gmail.com WhatsApp: +8801814901991 #HealthDynamics #ResearchPaper #JournalPublication #ScientificJournal #ArticlePublication

🌟Research Alert: Unveiling the Connections Between Myopia and Age-Related Eye Diseases 🌟 The Journal of Advanced Research in Medical and Health Science (ISSN 2208-2425) proudly presents a groundbreaking study titled: "Differential Associations of Myopia with Major Age-Related Eye Diseases: A Systematic Review". research paper by Alyssa Claudia Valerie Gunawan, Aquirina Caesari Putri, Fulgensius Atin, Universitas Katolik Widya Mandala Surabaya, 📌 Highlights of the Study: 🔬 Explores the nuanced relationships between myopia and key age-related eye diseases. 🔗 Provides a comprehensive analysis of the differential associations that could redefine our understanding of eye health. 📖 Published in Volume 9, Issue 12, 2023, this systematic review stands as a critical resource for ophthalmologists, researchers, and healthcare professionals. 🔑 Keywords: Association | Myopia | Age-Related Eye Disease 💡 Why This Matters: With the global prevalence of myopia rising, this research offers timely insights into its potential impact on age-related conditions like cataracts, glaucoma, and macular degeneration. 📢 Dive into the full study to stay at the forefront of medical and health science advancements. 👉 Read the Full Article Here: https://lnkd.in/g9drGMB4 Join us in exploring this important research and share your thoughts in the comments! 📢 Follow the Journal of Advanced Research in Medical and Health Science for more cutting-edge research and updates. #MedicalResearch #EyeHealth #Myopia #Ophthalmology #SystematicReview

🌟Publication Alert! 🌟 We are excited to announce the publication of systematic review titled “Association of Obesity and Psoriasis: A Ten Years Systematic Review.” research paper by Putri Kusuma Wardani, Yhoaninda Nurul ilmi, Universitas Islam Sultan Agung Semarang 📖 Keywords: Psoriasis, Obesity This comprehensive review explores the intricate relationship between obesity and psoriasis over the past decade, highlighting the impact of body weight on the severity and management of this chronic skin condition. As obesity rates continue to rise globally, understanding its association with psoriasis becomes increasingly vital for effective treatment strategies. 🔍 Key Findings Include: The prevalence of psoriasis in individuals with obesity. Mechanistic links between obesity and the exacerbation of psoriasis symptoms. Implications for clinical practice and patient management. Join us in advancing the conversation on the intersection of dermatology and public health! 📬 Read the full article and discover more about our research efforts in medical and health science by visiting our journal's website: https://lnkd.in/gRZFCNKC #Psoriasis #Obesity #SystematicReview #HealthScience #MedicalResearch #JournalPublication #PublicHealth

𝗔𝗺𝗲𝗻𝗼𝗿𝗿𝗵𝗲𝗮 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟭. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The research report provides a comprehensive overview of the Amenorrhea Treatment industry chain, assessing the market status of treatment options offered in hospitals and clinics, including Hormone Treatment and Oral Birth Control Pills. It also identifies key enterprises operating in both developed and developing markets and analyzes the latest technology advancements, patents, and emerging applications within the Amenorrhea Treatment sector. Regionally, North America and Europe are witnessing consistent growth, supported by government initiatives and heightened consumer awareness. Meanwhile, Asia-Pacific, particularly China, stands out as the global leader in the Amenorrhea Treatment market, benefiting from robust domestic demand, favorable policies, and a well-established manufacturing base. The market segmentation by Type and Application allows for precise calculations and forecasts of consumption value by Type and Application in terms of value for the period 2024-2031. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗔𝗺𝗲𝗻𝗼𝗿𝗿𝗵𝗲𝗮 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/d8uMXnni *𝗕𝘆 𝗧𝘆𝗽𝗲: Hormone Treatment, Oral Birth Control Pills, Others *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻:  Hospital, Clinics *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Teva Pharmaceuticals, Pfizer, Dr. Reddy's Laboratories, Akorn Pharmaceuticals #amenorrhea #womenshealth #menstruation #hormonalimbalance #healthcare #reproductivehealth #amenorrheatreatment #hormonalhealth #menstrualhealth #healthandwellness #hormonaldisorder #healthmanagement #womenswellness #hormonaltherapy #medicaltreatment #hormonalregulation #healthcareproviders #hormonalissues #menstrualcycle #womensupport #healthylifestyle #medicalcare #hormonalimbalance #hormonalchanges #menstrualdisorders #healthandfitness #healthyliving #hormonalhealthcare #healthprofessionals #reproductivemedicine

A sample of health research initiatives being funded by the Health Research Council. It shows how funding is diverted away from useful remedies, like cancer drugs, and into quack remedies based on racial preference; • $650k for Hapai te hauora: Breathing your ancestors into life, captures the breadth & connections of a generation – rangatahi Māori–a generation moving forward together •$400k for access of traditional Maori healing for cancer care services •$380k for Kaupapa Māori music theories and practices as a pathway to accelerating Māori well-being •$150k for interviews with Pacific men, Pacific heath promoters and Pacific barbers will inform the development of a Pacific health promoting behaviour change framework and intervention programme in a barbershop setting owned by a Pacific health provider •$150k to redesign hospital waiting rooms away from “a legacy founded in colonialism and are designed to Eurocentric principles of health and well-being“ •$400k to research traditional Māori lunar calendar system guided by the goddess Hine te Iwaiwa, into the context of pregnancy care for wāhine Māori and Maori Midwives.” •$650k to fund build on her expertise in kappa Māori research and enable her to pursue a development and capacity building plan to grow both her expertise and that of emerging researchers. I thought the Tohunga Suppression Act 1907, supported by Maori leaders, was introduced to ban this kind of dodgy practice. It seems they have re-emerged.

𝐁𝐚𝐜𝐭𝐞𝐫𝐢𝐚𝐥 𝐕𝐚𝐠𝐢𝐧𝐨𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐀𝐝𝐝𝐫𝐞𝐬𝐬𝐢𝐧𝐠 𝐖𝐨𝐦𝐞𝐧'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡 𝐰𝐢𝐭𝐡 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐆𝐞𝐭 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨: https://lnkd.in/eZcthd7g As awareness of women's health issues continues to rise, the Bacterial Vaginosis (BV) market is gaining significant attention for providing critical treatments in reproductive health. Bacterial vaginosis, a common yet under-discussed condition, affects millions of women worldwide, and the healthcare industry is responding with innovative solutions. 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬: Rising Awareness: Increasing initiatives to raise awareness about women’s reproductive health is boosting demand for effective BV diagnostics and treatments. Advances in Therapeutics: The market is witnessing the development of more effective and accessible antibiotics, probiotics, and non-antibiotic treatments to reduce recurrence rates and improve patient outcomes. Technology Integration: Digital health platforms are playing a vital role in offering easier access to treatment, telemedicine consultations, and improved patient education. 𝐆𝐥𝐨𝐛𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: North America leads the market due to strong healthcare infrastructure and higher awareness, while Asia-Pacific is experiencing rapid growth driven by increasing healthcare accessibility. Why It Matters: With BV linked to increased risks of preterm birth and other complications, it’s essential to focus on early detection and effective treatment. As research advances, the BV market is poised to address this widespread condition with more targeted, patient-friendly therapies. Looking Ahead: Innovations in personalized medicine and microbiome-targeted therapies hold the promise of reshaping the treatment landscape for bacterial vaginosis, offering a better quality of life for millions of women globally. #BacterialVaginosis #WomensHealth #HealthcareInnovation #ReproductiveHealth #MedicalResearch #MarketTrends #Pharmaceuticals #PatientCare #HealthAwareness

The physiology of menopause and perimenopause has been understudied. However, wearable device leader ŌURA and period tracker startup Clue are now teaming up with academic researchers to change that. This gap in research isn’t limited to women entering menopause. Until the 1980s, women of reproductive age were largely excluded from clinical research. Hormonal fluctuations were seen as confounding factors, and the assumption was made that the male body could serve as a general model for all people. Now, researchers are working to fill the knowledge gaps we've inherited. I’m a big fan of democratising research, and I’m thrilled to see that women’s health is finally being taken seriously. Many founders are focusing on this critical area. A few notable ones include Susanne Feldt with Hermaid, a virtual women's clinic providing access to medical advice on hormone imbalances, especially for women going through menopause; Samina Usman, founder of Femilog® , Menopause Health Tracker; Prof. Sharron Hinchliff, companies like Midi Health; Elektra Health and many more. Source: MedTech Pulse.

Closing 2024, I'm pleased to share that my latest research paper has been published in the Jurnal Keperawatan Padjadjaran. 📄 Title: The Unmet Needs of Palliative Care among Patients with Non-Malignant Chronic Illness in Indonesia: A Phenomenology Study 🔍 Abstract: This study explores the experiences and needs of patients diagnosed with non-malignant chronic illnesses in Indonesia. Through semi-structured interviews, we identified six major themes that highlight the challenges these patients face, including negative emotions, ignorance of the disease process, helplessness during treatment, feelings of being a burden, limited access to care, and the role of family and faith as sources of motivation. Our findings emphasize the need for broader and deeper palliative care assessments for non-malignant chronic illness patients. 👥 Authors: Rona Cahyantari Merduaty, Tuti Nuraini, Sihwastuti Sihwastuti 📚 Read the full paper here: https://lnkd.in/ghEJ8zj6 This research is very close to my heart as it addresses the often-overlooked needs of patients with non-malignant chronic illnesses. This research also marks the beginning of my career as academia. Working on this project has been a deeply rewarding experience, and I am grateful for the support of my co-authors and everyone involved. I hope our findings will contribute to better palliative care practices and improve the quality of life for many. Thank you for taking the time to read about our work. Let's continue to work towards improving palliative care for all patients. #Research #PalliativeCare #ChronicIllness #Nursing #Publication

🚨 N E W R E S E A R C H 🚨 A small-scale study just out of China shows promising results in the use of an anti-malaria drug (a herbal extract called artemisinin) in reducing testosterone production in the ovary While this is an incredibly exciting development, we must advise on cautious optimism and patience. The study is very small, only 19 patients over 12 weeks, so a larger scale study (or studies plural!) over a longer period of time need to be done before these findings could be adopted. ❓Why does this study matter❓ As you know only too well, treatment and management of PCOS is currently on a symptom by symptom basis and there is no licenced medicine to treat the underlying cause. Quoted in The Guardian, Professor Qi-qun Tang, research lead from Fudan University in Shangai said, “Based on our findings, artemisinins are promising candidates for treating PCOS because they strongly inhibit ovarian androgen synthesis, reduce immature follicles, and improve the [menstrual] cycle.” 🔍 Future Research Needed 🔎 🔬Long-Term Health Risks: Understanding any potential long-term side effects. 🔬Fertility and Pregnancy: Investigating effects on fertility and pregnancy (on both mother and baby) 🔬Effect beyond restoring menstrual cycle: Does it improve androgen related symptoms, insulin resistance, quality of life etc 👩🏻💻 Would you like a webinar on this research? 👩🏾💻 We might host a webinar with experts to answer all your questions about this groundbreaking research, to find out what conclusions - if any - we can already draw, how soon might this lead to a PCOS medicine, what other research it might lead too etc. Is this of interest? Comment Yes below if you’re interested. What do you think? Are you excited? Sceptical? We would love your thoughts on this new research, drop comments below ⬇️ Scientific Paper https://lnkd.in/etbWrwqJ Guardian Article https://lnkd.in/gZRsAs_K #pcos #research #pcosresearch #breakthrough #pcoswebinar #malaria #artemisinin #hormoneimbalance

This morning at the ADLabs Pop-Up we had a great time learning how Ovulio Corp. uses AI to determine ovulation status with co-founders Dr. Serhii Zatsarynin, PhD and Kateryna Andreeva 👏 Some key takeaways 👇 1️⃣ This is the beginning days of AI in fertility technology. Ovul uses AI to detect changes in saliva to find ovulation days 🔍 2️⃣ As estrogen levels increase, a "ferning" or crystallization pattern forms in dried saliva. Ovul has trained AI models to detect this pattern using their device! 3️⃣ This technology can be used outside of fertility tracking, to catch changes in estrogen levels when entering perimenopause and menopause. Stay tuned for the full interview soon 🧬 🪩 🤍 Visit Ovul to learn more: https://lnkd.in/gEkGZ9dR